logo

Imv Inc. (IMV)



Trade IMV now with
  Date
  Headline
12/28/2020 7:09:47 AM IMV Reports Update On Development Of Its Vaccine Candidate, DPX-COVID-19
12/3/2020 7:31:30 AM IMV Reports Updated Clinical And Translational Data From Phase 2 clinical Study Of DPX-Survivac
11/12/2020 7:29:10 AM IMV Q3 Loss/Shr C$0.13 Vs Loss C$0.16 Last Year
11/9/2020 8:18:27 AM IMV: T Cell Therapy Show 86% Objective Response Rate In Combination With Keytruda In PD-L1 Patients With R/r DLBCL
10/8/2020 7:11:31 AM IMV Provides Updates On Vaccine Candidate, DPX-COVID-19
7/20/2020 7:08:41 AM IMV Inc. Says Appoints Michael Bailey To Its Board
7/14/2020 7:40:18 AM IMV Provides Further Details On COVID-19 Vaccine Program
5/21/2020 7:17:21 AM IMV Inc. Announces Positive Preclinical Results Demonstrating Immunogenic And Antibody Responses From Peptide Epitopes
5/15/2020 7:11:39 AM IMV Q1 Total Revenue C$68K Vs. C$82K Prior Year
3/30/2020 7:17:20 AM IMV Provides Updates On Development Of DPX-COVID-19